| SC 13G/A | 2024-02-14 | BIOTECHNOLOGY VALUE FUND L P | Verastem, Inc. | 1,394,241 | 5.4% | EDGAR |
| SC 13G/A | 2024-02-14 | ORBIMED ADVISORS LLC | Verastem, Inc. | 1,529,115 | 6.1% | EDGAR |
| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Verastem, Inc. | 2,531,829 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-13 | Vivo Opportunity, LLC | Verastem, Inc. | 1,538,461 | 6.1% | EDGAR |
| SC 13G/A | 2024-02-02 | Soleus Capital Master Fund, L.P. | Verastem, Inc. | 1,425,634 | 6.8% | EDGAR |
| SC 13G | 2023-08-31 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Verastem, Inc. | 1,300,000 | 5.2% | EDGAR |
| SC 13G/A | 2023-08-10 | BAKER BROS. ADVISORS LP | Verastem, Inc. | - | 0.0% | EDGAR |
| SC 13G | 2023-07-27 | Soleus Capital Master Fund, L.P. | Verastem, Inc. | 1,297,369 | 5.1% | EDGAR |
| SC 13G | 2023-06-23 | Flynn James E | Verastem, Inc. | 1,538,461 | 6.1% | EDGAR |
| SC 13G/A | 2023-06-12 | BAKER BROS. ADVISORS LP | Verastem, Inc. | 1,345,192 | 8.0% | EDGAR |
| SC 13G | 2023-06-05 | VIKING GLOBAL INVESTORS LP | Verastem, Inc. | 1,320,656 | 7.9% | EDGAR |
| SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | Verastem, Inc. | 11,193,509 | 5.6% | EDGAR |
| SC 13G/A | 2023-02-14 | BAKER BROS. ADVISORS LP | Verastem, Inc. | 26,988,898 | 13.5% | EDGAR |
| SC 13G | 2023-02-14 | ORBIMED ADVISORS LLC | Verastem, Inc. | 12,354,337 | 5.9% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Verastem, Inc. | 4,337,334 | 2.3% | EDGAR |
| SC 13G/A | 2022-02-14 | BAKER BROS. ADVISORS LP | Verastem, Inc. | 21,491,630 | 11.8% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | Verastem, Inc. | 8,849,796 | 4.9% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Verastem, Inc. | 12,328,248 | 6.8% | EDGAR |
| SC 13G/A | 2022-01-10 | BIOTECHNOLOGY VALUE FUND L P | Verastem, Inc. | 8,824,237 | 4.8% | EDGAR |
| SC 13G/A | 2022-01-10 | BIOTECHNOLOGY VALUE FUND L P | Verastem, Inc. | 9,578,709 | 5.3% | EDGAR |